Arghya Ray

Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl

Ellen Weisberg, Paul W. Manley, Werner Breitenstein et al. · Cancer Cell · 2005 · 1.5K citations · Full text

Molecular Pharmacology, Mutant Bcr-abl, Medicine +5

A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance

Ze Tian, Pádraig D’Arcy, Xin Wang et al. · Blood · 2013 · 310 citations · Full text

Characterization of PNA and DNA Immobilization and Subsequent Hybridization with DNA Using Acoustic-Shear-Wave Attenuation Measurements

Fredrik Höök, Arghya Ray, Bengt Nordén et al. · Langmuir · 2001 · 215 citations

Identification of BCR-ABL point mutations conferring resistance to the Abl kinase inhibitor AMN107 (nilotinib) by a random mutagenesis study

Arghya Ray, Sandra W. Cowan‐Jacob, Paul W. Manley et al. · Blood · 2007 · 135 citations · Full text

Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism

Nathan J. Schauer, Xiaoxi Liu, Robert S. Magin et al. · Scientific Reports · 2020 · 115 citations · Full text

Selective Usp7 Inhibition, Apoptosis, Cell Death +20